Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(1-[2-oxo-2-[(pyridin-3-ylmethyl)amino]ethyl]cyclopentyl)acetic acid | 11% inhibition at 0.001 mM | Homo sapiens | |
(1-[2-[(2,4-dichlorobenzyl)amino]-2-oxoethyl]cyclopentyl)acetic acid | 27% inhibition at 0.001 mM | Homo sapiens | |
(1-[2-[(2-chloro-4-fluorobenzyl)amino]-2-oxoethyl]cyclopentyl)acetic acid | - |
Homo sapiens | |
(1-[2-[(2-chlorobenzyl)amino]-2-oxoethyl]cyclopentyl)acetic acid | 22% inhibition at 0.001 mM | Homo sapiens | |
(1-[2-[(4-methoxypyridin-3-yl)amino]-2-oxoethyl]cyclopentyl)acetic acid | 7% inhibition at 0.001 mM | Homo sapiens | |
(1-[2-[(cyclohexylmethyl)amino]-2-oxoethyl]cyclopentyl)acetic acid | 7% inhibition at 0.001 mM | Homo sapiens | |
(1r,4s)-4-[[5-(cyclopropylamino)-3,3-dimethyl-5-oxopentanoyl]amino]tricyclo[3.3.1.13,7]decane-1-carboxylic acid | - |
Homo sapiens | |
2-(1-[2-oxo-2-[(pyridin-2-ylmethyl)amino]ethyl]cyclopentyl)-N-tricyclo[3.3.1.13,7]dec-2-ylacetamide | - |
Homo sapiens | |
2-(1-[2-[(2-methoxyphenyl)amino]-2-oxoethyl]cyclopentyl)-N-tricyclo[3.3.1.13,7]dec-2-ylacetamide | - |
Homo sapiens | |
2-(1-[2-[(2-methylpropyl)amino]-2-oxoethyl]cyclopentyl)-N-tricyclo[3.3.1.13,7]dec-2-ylacetamide | - |
Homo sapiens | |
2-(1-[2-[(4-fluorobenzyl)amino]-2-oxoethyl]cyclopentyl)-N-tricyclo[3.3.1.13,7]dec-2-ylacetamide | - |
Homo sapiens | |
2-(1-[2-[(4-fluorophenyl)amino]-2-oxoethyl]cyclopentyl)-N-tricyclo[3.3.1.13,7]dec-2-ylacetamide | - |
Homo sapiens | |
2-(1-[2-[(4-methoxyphenyl)amino]-2-oxoethyl]cyclopentyl)-N-tricyclo[3.3.1.13,7]dec-2-ylacetamide | - |
Homo sapiens | |
2-[1-(2-oxo-2-pyrrolidin-1-ylethyl)cyclopentyl]-N-tricyclo[3.3.1.13,7]dec-2-ylacetamide | - |
Homo sapiens | |
2-[1-[2-(4-ethylpiperazin-1-yl)-2-oxoethyl]cyclopentyl]-N-tricyclo[3.3.1.13,7]dec-2-ylacetamide | - |
Homo sapiens | |
2-[1-[2-(benzylamino)-2-oxoethyl]cyclopentyl]-N-tricyclo[3.3.1.13,7]dec-2-ylacetamide | - |
Homo sapiens | |
2-[1-[2-(cyclopropylamino)-2-oxoethyl]cyclohexyl]-N-tricyclo[3.3.1.13,7]dec-2-ylacetamide | - |
Homo sapiens | |
2-[1-[2-(cyclopropylamino)-2-oxoethyl]cyclopentyl]-N-tricyclo[3.3.1.13,7]dec-2-ylacetamide | - |
Homo sapiens | |
3,3-dimethyl-4-(3-pyridin-2-yl-1,2,4-oxadiazol-5-yl)-N-tricyclo[3.3.1.13,7]dec-2-ylbutanamide | - |
Homo sapiens | |
3,3-dimethyl-4-[3-(1-methylethyl)-1,2,4-oxadiazol-5-yl]-N-tricyclo[3.3.1.13,7]dec-2-ylbutanamide | - |
Homo sapiens | |
4-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-3,3-dimethyl-N-tricyclo[3.3.1.13,7]dec-2-ylbutanamide | - |
Homo sapiens | |
4-[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]-3,3-dimethyl-N-tricyclo[3.3.1.13,7]dec-2-ylbutanamide | - |
Homo sapiens | |
N-cyclopropyl-3,3-dimethyl-N'-tricyclo[3.3.1.13,7]dec-2-ylpentanediamide | - |
Homo sapiens | |
N-cyclopropyl-N'-tricyclo[3.3.1.13,7]dec-2-ylpentanediamide | - |
Homo sapiens | |
N-cyclopropyl-N'-[(2R)-1-hydroxytricyclo[3.3.1.13,7]dec-2-yl]-3,3-dimethylpentanediamide | - |
Homo sapiens | |
N-cyclopropyl-N'-[(2r,5s)-5-hydroxytricyclo[3.3.1.13,7]dec-2-yl]-3,3-dimethylpentanediamide | - |
Homo sapiens | |
N-[(2s,5r)-5-carbamoyltricyclo[3.3.1.13,7]dec-2-yl]-N'-cyclopropyl-3,3-dimethylpentanediamide | - |
Homo sapiens | |
[1-[2-(cyclohexylamino)-2-oxoethyl]cyclopentyl]acetic acid | 13% inhibition at 0.001 mM | Homo sapiens | |
[1-[2-(octahydroisoquinolin-2(1H)-yl)-2-oxoethyl]cyclopentyl]acetic acid | 34% inhibition at 0.001 mM | Homo sapiens | |
[1-[2-oxo-2-(tricyclo[3.3.1.13,7]dec-1-ylamino)ethyl]cyclopentyl]acetic acid | 8% inhibition at 0.001 mM | Homo sapiens | |
[1-[2-oxo-2-(tricyclo[3.3.1.13,7]dec-2-ylamino)ethyl]cyclopentyl]acetic acid | - |
Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P28845 | - |
- |
Synonyms | Comment | Organism |
---|---|---|
11beta-HSD | - |
Homo sapiens |
11beta-hydroxysteroid dehydrogenase type I | - |
Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.000008 | - |
in 30 mM HEPES buffer, pH 7.4, at 37°C | Homo sapiens | 3,3-dimethyl-4-[3-(1-methylethyl)-1,2,4-oxadiazol-5-yl]-N-tricyclo[3.3.1.13,7]dec-2-ylbutanamide | |
0.000008 | - |
in 30 mM HEPES buffer, pH 7.4, at 37°C | Homo sapiens | N-[(2s,5r)-5-carbamoyltricyclo[3.3.1.13,7]dec-2-yl]-N'-cyclopropyl-3,3-dimethylpentanediamide | |
0.000008 | - |
in 30 mM HEPES buffer, pH 7.4, at 37°C | Homo sapiens | N-cyclopropyl-N'-[(2r,5s)-5-hydroxytricyclo[3.3.1.13,7]dec-2-yl]-3,3-dimethylpentanediamide | |
0.000009 | - |
in 30 mM HEPES buffer, pH 7.4, at 37°C | Homo sapiens | 2-(1-[2-[(2-methoxyphenyl)amino]-2-oxoethyl]cyclopentyl)-N-tricyclo[3.3.1.13,7]dec-2-ylacetamide | |
0.000009 | - |
in 30 mM HEPES buffer, pH 7.4, at 37°C | Homo sapiens | 2-(1-[2-[(2-methylpropyl)amino]-2-oxoethyl]cyclopentyl)-N-tricyclo[3.3.1.13,7]dec-2-ylacetamide | |
0.000012 | - |
in 30 mM HEPES buffer, pH 7.4, at 37°C | Homo sapiens | 4-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-3,3-dimethyl-N-tricyclo[3.3.1.13,7]dec-2-ylbutanamide | |
0.000016 | - |
in 30 mM HEPES buffer, pH 7.4, at 37°C | Homo sapiens | 2-(1-[2-oxo-2-[(pyridin-2-ylmethyl)amino]ethyl]cyclopentyl)-N-tricyclo[3.3.1.13,7]dec-2-ylacetamide | |
0.000017 | - |
in 30 mM HEPES buffer, pH 7.4, at 37°C | Homo sapiens | 2-(1-[2-[(4-fluorophenyl)amino]-2-oxoethyl]cyclopentyl)-N-tricyclo[3.3.1.13,7]dec-2-ylacetamide | |
0.000018 | - |
in 30 mM HEPES buffer, pH 7.4, at 37°C | Homo sapiens | 2-(1-[2-[(4-fluorobenzyl)amino]-2-oxoethyl]cyclopentyl)-N-tricyclo[3.3.1.13,7]dec-2-ylacetamide | |
0.000019 | - |
in 30 mM HEPES buffer, pH 7.4, at 37°C | Homo sapiens | 2-[1-[2-(benzylamino)-2-oxoethyl]cyclopentyl]-N-tricyclo[3.3.1.13,7]dec-2-ylacetamide | |
0.000048 | - |
in 30 mM HEPES buffer, pH 7.4, at 37°C | Homo sapiens | 2-(1-[2-[(4-methoxyphenyl)amino]-2-oxoethyl]cyclopentyl)-N-tricyclo[3.3.1.13,7]dec-2-ylacetamide | |
0.000048 | - |
in 30 mM HEPES buffer, pH 7.4, at 37°C | Homo sapiens | 2-[1-(2-oxo-2-pyrrolidin-1-ylethyl)cyclopentyl]-N-tricyclo[3.3.1.13,7]dec-2-ylacetamide | |
0.000057 | - |
in 30 mM HEPES buffer, pH 7.4, at 37°C | Homo sapiens | 3,3-dimethyl-4-(3-pyridin-2-yl-1,2,4-oxadiazol-5-yl)-N-tricyclo[3.3.1.13,7]dec-2-ylbutanamide | |
0.00006 | - |
in 30 mM HEPES buffer, pH 7.4, at 37°C | Homo sapiens | 2-[1-[2-(cyclopropylamino)-2-oxoethyl]cyclopentyl]-N-tricyclo[3.3.1.13,7]dec-2-ylacetamide | |
0.00015 | - |
in 30 mM HEPES buffer, pH 7.4, at 37°C | Homo sapiens | N-cyclopropyl-3,3-dimethyl-N'-tricyclo[3.3.1.13,7]dec-2-ylpentanediamide | |
0.00016 | - |
in 30 mM HEPES buffer, pH 7.4, at 37°C | Homo sapiens | 2-[1-[2-(4-ethylpiperazin-1-yl)-2-oxoethyl]cyclopentyl]-N-tricyclo[3.3.1.13,7]dec-2-ylacetamide | |
0.0002 | - |
in 30 mM HEPES buffer, pH 7.4, at 37°C | Homo sapiens | 4-[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]-3,3-dimethyl-N-tricyclo[3.3.1.13,7]dec-2-ylbutanamide | |
0.00034 | - |
in 30 mM HEPES buffer, pH 7.4, at 37°C | Homo sapiens | 2-[1-[2-(cyclopropylamino)-2-oxoethyl]cyclohexyl]-N-tricyclo[3.3.1.13,7]dec-2-ylacetamide | |
0.00055 | - |
in 30 mM HEPES buffer, pH 7.4, at 37°C | Homo sapiens | N-cyclopropyl-N'-[(2R)-1-hydroxytricyclo[3.3.1.13,7]dec-2-yl]-3,3-dimethylpentanediamide | |
0.001 | - |
IC50 above 0.001 mM, in 30 mM HEPES buffer, pH 7.4, at 37°C | Homo sapiens | N-cyclopropyl-N'-tricyclo[3.3.1.13,7]dec-2-ylpentanediamide | |
0.001 | - |
IC50 above 0.001 mM, in 30 mM HEPES buffer, pH 7.4, at 37°C | Homo sapiens | (1r,4s)-4-[[5-(cyclopropylamino)-3,3-dimethyl-5-oxopentanoyl]amino]tricyclo[3.3.1.13,7]decane-1-carboxylic acid | |
0.0012 | - |
- |
Homo sapiens | (1-[2-[(2-chloro-4-fluorobenzyl)amino]-2-oxoethyl]cyclopentyl)acetic acid | |
0.0018 | - |
in 30 mM HEPES buffer, pH 7.4, at 37°C | Homo sapiens | [1-[2-oxo-2-(tricyclo[3.3.1.13,7]dec-2-ylamino)ethyl]cyclopentyl]acetic acid |